LICENSING NEWS AND EVENTS

Merck is active in deal-making worldwide.

Come meet us at an upcoming event.

January 11-14, 2010   JP Morgan Annual Healthcare Conference

San Francisco, California

Read about our recent partnerships.

Jul 22, 2009   Depomed Provides License For Patents Covering Metformin Extended Release Technology to Merck & Co., Inc.
Apr 27, 2009   UTSA, Health Science Center Collaborate With Merck & Co., Inc. to Develop Chlamydia Vaccine
Apr 21, 2009   Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection
Apr 15, 2009   Merck & Co., Inc. and Santen Sign Licensing Agreement In Ophthalmology
Apr 08, 2009   Merck & Co., Inc. and Cardiome Sign License Agreement for Vernakalant, an Investigational Drug for Treatment of Atrial Fibrillation
Mar 23, 2009   Xencor Licenses Xtend™ Antibody Half-life Prolongation Platform to Merck & Co., Inc.
Feb 12, 2009   Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
Jan 9, 2009   Galapagos Enters Strategic Alliance in Diabetes and Obesity
Jul 28, 2009   Cardiome Achieves Milestone from Collaboration with Merck & Co., Inc.
Jul 22, 2009   MicroDose Therapeutx Announces Expansion of Collaboration with Merck & Co., Inc for Dry Powder Inhaler Technology
Jul 10, 2009   Addex Achieves Second Milestone in Parkinson’s Disease Collaboration with Merck & Co., Inc.
Jun 16, 2009   Adimab Launches Novel Antibody Discovery Platform and Announces Discovery Programs with Merck and Roche
Jun 11, 2009   GTx Presents Phase II Ostarine (MK-2866) Cancer Cachexia Clinical Trial Results at Endocrine Society Annual Meeting
"We welcome partnerships at all stages of discovery and development. As our partner, you will find that Merck is highly committed to ensuring the success of the opportunity through high prioritization, close collaboration, and the excellence of our research, development, marketing, and sales organizations."
Pamela Demain, MBA, CLP
Executive Director, Corporate Licensing

RECENT PRESS RELEASES

Recent Press Releases Press releases